Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Alexander M. Lesokhin; Michael H. Tomasson; Bertrand Arnulf; Nizar J. Bahlis; H. Miles Prince; Ruben Niesvizky; Paula Rodrίguez-Otero; Joaquin Martinez-Lopez; Guenther Koehne; Cyrille Touzeau; Yogesh Jethava; Hang Quach; Julien Depaus; Hisayuki Yokoyama; Afshin Eli Gabayan; Don A. Stevens; Ajay K. Nooka; Salomon Manier; Noopur Raje; Shinsuke Iida; Marc Steffen Raab; Emma Searle; Eric Leip; Sharon T. Sullivan; Umberto Conte; Mohamed Elmeliegy; Akos Czibere; Andrea Viqueira; Mohamad Mohty

doi:10.1038/s41591-023-02528-9

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Alexander M. Lesokhin
, Michael H. Tomasson
, Bertrand Arnulf
, Nizar J. Bahlis
, H. Miles Prince
, Ruben Niesvizky
, Paula Rodrίguez-Otero
, Joaquin Martinez-Lopez
, Guenther Koehne
, Cyrille Touzeau
, Yogesh Jethava
, Hang Quach
, Julien Depaus
, Hisayuki Yokoyama
, Afshin Eli Gabayan
, Don A. Stevens
, Ajay K. Nooka
, Salomon Manier
, Noopur Raje
, Shinsuke Iida

Marc Steffen Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2259-2267
Number of pages	9
Journal	Nature medicine
Volume	29
Issue number	9
DOIs	https://doi.org/10.1038/s41591-023-02528-9
State	Published - Sep 2023

ASJC Scopus Subject Areas

General Medicine
General Biochemistry,Genetics and Molecular Biology

Access to Document

10.1038/s41591-023-02528-9

Cite this

Lesokhin, A. M., Tomasson, M. H., Arnulf, B., Bahlis, N. J., Miles Prince, H., Niesvizky, R., Rodrίguez-Otero, P., Martinez-Lopez, J., Koehne, G., Touzeau, C., Jethava, Y., Quach, H., Depaus, J., Yokoyama, H., Gabayan, A. E., Stevens, D. A., Nooka, A. K., Manier, S., Raje, N., ... Mohty, M. (2023). Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results. Nature medicine, 29(9), 2259-2267. https://doi.org/10.1038/s41591-023-02528-9

Lesokhin, AM, Tomasson, MH, Arnulf, B, Bahlis, NJ, Miles Prince, H, Niesvizky, R, Rodrίguez-Otero, P, Martinez-Lopez, J, Koehne, G, Touzeau, C, Jethava, Y, Quach, H, Depaus, J, Yokoyama, H, Gabayan, AE, Stevens, DA, Nooka, AK, Manier, S, Raje, N, Iida, S, Raab, MS, Searle, E, Leip, E, Sullivan, ST, Conte, U, Elmeliegy, M, Czibere, A, Viqueira, A & Mohty, M 2023, 'Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results', Nature medicine, vol. 29, no. 9, pp. 2259-2267. https://doi.org/10.1038/s41591-023-02528-9

@article{15299172c0b44a69b59316043437c3cd,

title = "Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results",

author = "Lesokhin, \{Alexander M.\} and Tomasson, \{Michael H.\} and Bertrand Arnulf and Bahlis, \{Nizar J.\} and \{Miles Prince\}, H. and Ruben Niesvizky and Paula Rodrίguez-Otero and Joaquin Martinez-Lopez and Guenther Koehne and Cyrille Touzeau and Yogesh Jethava and Hang Quach and Julien Depaus and Hisayuki Yokoyama and Gabayan, \{Afshin Eli\} and Stevens, \{Don A.\} and Nooka, \{Ajay K.\} and Salomon Manier and Noopur Raje and Shinsuke Iida and Raab, \{Marc Steffen\} and Emma Searle and Eric Leip and Sullivan, \{Sharon T.\} and Umberto Conte and Mohamed Elmeliegy and Akos Czibere and Andrea Viqueira and Mohamad Mohty",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = sep,

doi = "10.1038/s41591-023-02528-9",

language = "English",

volume = "29",

pages = "2259--2267",

journal = "Nature medicine",

issn = "1078-8956",

number = "9",

}

TY - JOUR

T1 - Elranatamab in relapsed or refractory multiple myeloma

T2 - phase 2 MagnetisMM-3 trial results

AU - Lesokhin, Alexander M.

AU - Tomasson, Michael H.

AU - Arnulf, Bertrand

AU - Bahlis, Nizar J.

AU - Miles Prince, H.

AU - Niesvizky, Ruben

AU - Rodrίguez-Otero, Paula

AU - Martinez-Lopez, Joaquin

AU - Koehne, Guenther

AU - Touzeau, Cyrille

AU - Jethava, Yogesh

AU - Quach, Hang

AU - Depaus, Julien

AU - Yokoyama, Hisayuki

AU - Gabayan, Afshin Eli

AU - Stevens, Don A.

AU - Nooka, Ajay K.

AU - Manier, Salomon

AU - Raje, Noopur

AU - Iida, Shinsuke

AU - Raab, Marc Steffen

AU - Searle, Emma

AU - Leip, Eric

AU - Sullivan, Sharon T.

AU - Conte, Umberto

AU - Elmeliegy, Mohamed

AU - Czibere, Akos

AU - Viqueira, Andrea

AU - Mohty, Mohamad

PY - 2023/9

Y1 - 2023/9

UR - https://www.scopus.com/pages/publications/85168091800

UR - https://www.scopus.com/pages/publications/85168091800#tab=citedBy

U2 - 10.1038/s41591-023-02528-9

DO - 10.1038/s41591-023-02528-9

M3 - Article

C2 - 37582952

AN - SCOPUS:85168091800

SN - 1078-8956

VL - 29

SP - 2259

EP - 2267

JO - Nature medicine

JF - Nature medicine

IS - 9

ER -

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this